Safety, Tolerance, and Efficacy of Posaconazole Therapy in Patients with Nonmeningeal Disseminated or Chronic Pulmonary Coccidioidomycosis

Catanzaro, Antonio; A. Cloud, Gretchen; A. Stevens, David; Esophagus Levine, Barrett's; Williams, Pamela; H. Johnson, R.; Rendón, Adrián; F. Mirels, Laurence; E Lutz, J; Holloway, M.; N Galgiani, J

doi:10.1086/519937

Public

Safety, Tolerance, and Efficacy of Posaconazole Therapy in Patients with Nonmeningeal Disseminated or Chronic Pulmonary Coccidioidomycosis

Published in Clinical Infectious Diseases • Aug 8, 2007

Authors:

Antonio Catanzaro

Gretchen A. Cloud

David A. Stevens

Abstract

BACKGROUND: Coccidioidomycosis can be difficult to treat with available therapies, particularly in patients with progressive or disseminated disease. Posaconazole is a new azole antifungal with potent activity against Coccidioides species, the causative agent of coccidioidomycosis. METHODS: Twenty p...

Subject

Medicine

Posaconazole

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!